Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Walsh, T. R.
Right arrow Articles by Bennett, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walsh, T. R.
Right arrow Articles by Bennett, P. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy, Vol 40, 171-178, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy


ORIGINAL ARTICLES

Distribution and expression of beta-lactamase genes among Aeromonas spp

TR Walsh, RA Stunt, JA Nabi, AP MacGowan and PM Bennett
Bristol Centre for Antimicrobial Research and Evaluation, Department of Microbiology and Pathology, Medical School, University of Bristol, UK.

Clinical and environmental isolates of Aeromonas spp. (20 Aeromonas caviae, 33 Aeromonas veronii and 21 Aeromonas hydrophila) were examined for their ability to yield mutants derepressed for beta-lactamase production and for the distribution of the three chromosomally encoded beta-lactamase genes, ampS and cepS from A. veronii bv. sobria and cphA from A. hydrophila. Of these isolates, 100% and 96% of the isolates from A. hydrophila and A. caviae, respectively, yielded beta-lactamase derepressed mutants but only 38% of A. veronii isolates yielded the resistant phenotype at 37 degrees C. However, when tested at 30 degrees C, all isolates gave rise to the derepressed mutants, indicating a temperature effect on the control mechanism. All mutants had significantly higher beta-lactamase activity against ampicillin, oxacillin, cephaloridine and imipenem. Hybridization studies with cloned aeromonas beta-lactamase genes indicated that the cephalosporinase gene, cepS, is almost ubiquitous for the three species tested. The cphA gene cross-hybridized with all isolates of A. veronii and A. hydrophila but not to A. caviae isolates. In contrast, hybridization studies using ampS revealed that only 25% of A. caviae, 45% of A. veronii and 38% of A. hydrophila tested carried the ampS gene or one closely homologous to it. Nonetheless, strains that failed to hybridize with ampS showed two serine beta-lactamases when analysed by isoelectric focusing.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
M. B. Avison, P. Niumsup, K. Nurmahomed, T. R. Walsh, and P. M. Bennett
Role of the 'cre/blr-tag' DNA sequence in regulation of gene expression by the Aeromonas hydrophila {beta}-lactamase regulator, BlrA
J. Antimicrob. Chemother., February 1, 2004; 53(2): 197 - 202.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
A. Mencacci, E. Cenci, R. Mazzolla, S. Farinelli, F. D'Alo, M. Vitali, and F. Bistoni
Aeromonas veronii biovar veronii septicaemia and acute suppurative cholangitis in a patient with hepatitis B
J. Med. Microbiol., August 1, 2003; 52(8): 727 - 730.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
P. Niumsup, A. M. Simm, K. Nurmahomed, T. R. Walsh, P. M. Bennett, and M. B. Avison
Genetic linkage of the penicillinase gene, amp, and blrAB, encoding the regulator of {beta}-lactamase expression in Aeromonas spp.
J. Antimicrob. Chemother., June 1, 2003; 51(6): 1351 - 1358.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Bellais, D. Girlich, A. Karim, and P. Nordmann
EBR-1, a Novel Ambler Subclass B1 {beta}-Lactamase from Empedobacter brevis
Antimicrob. Agents Chemother., October 1, 2002; 46(10): 3223 - 3227.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
P. Niumsup and V. Wuthiekanun
Cloning of the class D {beta}-lactamase gene from Burkholderia pseudomallei and studies on its expression in ceftazidime-susceptible and -resistant strains
J. Antimicrob. Chemother., October 1, 2002; 50(4): 445 - 455.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
N. Franceschini, L. Boschi, S. Pollini, R. Herman, M. Perilli, M. Galleni, J.-M. Frere, G. Amicosante, and G. M. Rossolini
Characterization of OXA-29 from Legionella (Fluoribacter) gormanii: Molecular Class D beta -Lactamase with Unusual Properties
Antimicrob. Agents Chemother., December 1, 2001; 45(12): 3509 - 3516.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. M. Livermore, M. W. Carter, S. Bagel, B. Wiedemann, F. Baquero, E. Loza, H. P. Endtz, N. van den Braak, C. J. Fernandes, L. Fernandes, et al.
In Vitro Activities of Ertapenem (MK-0826) against Recent Clinical Bacteria Collected in Europe and Australia
Antimicrob. Agents Chemother., June 1, 2001; 45(6): 1860 - 1867.
[Abstract] [Full Text]


Home page
Antimicrob. Agents Chemother.Home page
W.-C. Ko, H.-C. Lee, Y.-C. Chuang, S.-H. Ten, C.-Y. Su, and J.-J. Wu
In Vitro and in Vivo Combinations of Cefotaxime and Minocycline against Aeromonas hydrophila
Antimicrob. Agents Chemother., April 1, 2001; 45(4): 1281 - 1283.
[Abstract] [Full Text]


Home page
J Antimicrob ChemotherHome page
M. B. Avison, P. Niumsup, T. R. Walsh, and P. M. Bennett
Aeromonas hydrophila AmpH and CepH {beta}-lactamases: derepressed expression in mutants of Escherichia coli lacking creB
J. Antimicrob. Chemother., November 1, 2000; 46(5): 695 - 702.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
W.-C. Ko, H.-M. Wu, T.-C. Chang, J.-J. Yan, and J.-J. Wu
Inducible beta -Lactam Resistance in Aeromonas hydrophila: Therapeutic Challenge for Antimicrobial Therapy
J. Clin. Microbiol., November 1, 1998; 36(11): 3188 - 3192.
[Abstract] [Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.